Document Preview Unavailable

Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib

Selaru, P; Tang, Y; Huang, B; Polli, A; Wilner, K D; et al.  Clinical and Translational Science Vol. 9, Iss. 2,  (Apr 2016): 63-73.

You might have access to this document